Could an experimental cancer drug hold the keys to a cure?

Finding a cure for cancer has always been seen as a vague pipe dream that will require an Einstein-like genius to discover and develop.

But a small study that began at the Memorial Sloan Kettering Cancer Center in New York in 2019 has yielded an incredible return: 100% of patients suffering from rectal cancer entered remission, without the need for follow-up chemotherapy treatment or surgery! 🙌🙌🙌

The study of 14 patients was published in The New England Journal of Medicine.

“I don’t think anyone has seen this before, where every single patient has had the tumour disappear,” Andrea Cercek, lead author of the study, told The Washington Post.

You’ll be hard-pressed to find someone who hasn’t felt the pain of losing a loved one to cancer or witnessing the devastating effects on the body that existing treatments have. 

These results are unprecedented and it has given many researchers and oncologists alike hope that the approach from the experimental drug trial can be used in efforts to cure other types of cancer. This includes immunotherapy treatment. 

We’re cautiously optimistic. This study may be small but still shows a tremendous amount of promise as mankind moves forward in our search for better treatment, or even a genuine cure, for cancer. And, in times like these, this is a giant piece of good news that we all need.

Leave a Comment

Your email address will not be published.